Microvascular rarefaction
暂无分享,去创建一个
[1] V. Znojil,et al. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. , 1996, Physiological research.
[2] Natalia Mendelev,et al. Endothelial-mesenchymal Transformation Chronic Nos Inhibition Actuates , 2006 .
[3] Youhua Liu. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.
[4] Andrew P. McMahon,et al. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature , 2005, Nature.
[5] Turgay Dalkara,et al. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery , 2009, Nature Medicine.
[6] W. Koch,et al. Vascular rarefaction in peripheral skeletal muscle after experimental heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.
[7] J. Hughes,et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. , 2001, Journal of the American Society of Nephrology : JASN.
[8] Natalia Mendelev,et al. Urinary proteomic analysis of chronic allograft nephropathy , 2008, Proteomics. Clinical applications.
[9] M. Menger,et al. Microvascular consequences of Kupffer cell modulation in rat liver fibrogenesis , 1999, The Journal of pathology.
[10] Shawn M. Sweeney,et al. Endorepellin, a Novel Inhibitor of Angiogenesis Derived from the C Terminus of Perlecan* , 2003, The Journal of Biological Chemistry.
[11] K. Camphausen,et al. Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. , 2006, Journal of the National Cancer Institute.
[12] Jun Yamashita,et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.
[13] A. Bikfalvi,et al. Tumor angiogenesis , 2020, Advances in cancer research.
[14] L. E. Watts,et al. Arteriolar rarefaction in the conjunctiva of human essential hypertensives. , 1978, Microvascular research.
[15] A. Yeung,et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. , 1996, Circulation.
[16] Samuel A. Santoro,et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin , 2004, The Journal of cell biology.
[17] A. Greene,et al. Rapid microvessel rarefaction with elevated salt intake and reduced renal mass hypertension in rats. , 1996, Circulation research.
[18] W. Kilarski,et al. Biomechanical regulation of blood vessel growth during tissue vascularization , 2009, Nature Medicine.
[19] B. Folkow. The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. , 1978, Clinical science and molecular medicine. Supplement.
[20] M. Frid,et al. Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial-Mesenchymal Transdifferentiation: In Vitro Analysis , 2002, Circulation research.
[21] Lindolfo da Silva Meirelles,et al. Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.
[22] R. Kalluri,et al. Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.
[23] H. Kitamura,et al. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. , 2000, Journal of the American Society of Nephrology : JASN.
[24] W. Montagna,et al. Structural changes in aging human skin. , 1979, The Journal of investigative dermatology.
[25] J. Folkman,et al. The sequence of events in the regression of corneal capillaries. , 1978, Laboratory investigation; a journal of technical methods and pathology.
[26] S. Harper,et al. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor , 2005, Diabetologia.
[27] P. Carmeliet. Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.
[28] M. Goligorsky,et al. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. , 2008, Kidney international.
[29] Ivar Giaever,et al. Permissive Role of Nitric Oxide in Endothelin-induced Migration of Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[30] B. Lévy,et al. Microvasculature in angiotensin II-dependent cardiac hypertrophy in the rat. , 1998, Hypertension.
[31] A Bohle,et al. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. , 1987, American journal of nephrology.
[32] N. Kashihara,et al. Implication of Peritubular Capillary Loss and Altered Expression of Vascular Endothelial Growth Factor in IgA Nephropathy , 2006, Nephron Physiology.
[33] Z. Ungvari,et al. The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach. , 2009, The American journal of pathology.
[34] T. Nakagawa,et al. Nitric oxide modulates vascular disease in the remnant kidney model. , 2002, The American journal of pathology.
[35] I. Manyonda,et al. Skin capillary density changes in normal pregnancy and pre-eclampsia , 2002, Journal of hypertension.
[36] C. Betsholtz,et al. Pericytes and vascular stability. , 2006, Experimental cell research.
[37] S. Pillarisetti. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity. , 2000, Trends in cardiovascular medicine.
[38] L. Truong,et al. Role of the microvascular endothelium in progressive renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[39] Ivar Giaever,et al. Podokinesis in endothelial cell migration: role of nitric oxide. , 1998, American journal of physiology. Cell physiology.
[40] S M Blinkov,et al. Rarefication of the arterioles and capillary network in the brain of rats with different forms of hypertension. , 1985, Microvascular research.
[41] E. Neilson,et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.
[42] P. Hutchins,et al. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. , 1997, Endocrinology.
[43] R. Mitchell,et al. Graft vascular disease: immune response meets the vessel wall. , 2009, Annual review of pathology.
[44] Lois E. H. Smith,et al. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. , 2003, The Journal of clinical investigation.
[45] M. Goligorsky,et al. Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition. , 2008, American journal of physiology. Renal physiology.
[46] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[47] M. Goligorsky,et al. Mesenchymal cells from adult kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin-producing fibroblasts. , 2006, American journal of physiology. Renal physiology.
[48] T. Veikkola,et al. Interaction of endostatin with integrins implicated in angiogenesis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. T. ter Maaten,et al. Impaired Skin Capillary Recruitment in Essential Hypertension Is Caused by Both Functional and Structural Capillary Rarefaction , 2001, Hypertension.
[50] B. Lévy,et al. Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt−/−) , 2002, Journal of hypertension.
[51] R. Prewitt,et al. Alterations in the microvasculature of one-kidney, one-clip hypertensive rats. , 1987, The American journal of physiology.
[52] M. Johnson,et al. Pressure-independent arteriolar rarefaction in hypertension. , 1991, The American journal of physiology.
[53] Jean Paul Thiery,et al. Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.
[54] A. Hudetz,et al. Percolation phenomenon: the effect of capillary network rarefaction. , 1993, Microvascular research.
[55] M. Zeier,et al. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. , 1996, Journal of the American Society of Nephrology : JASN.
[56] P. Tonellato,et al. Microvascular rarefaction and tissue vascular resistance in hypertension. , 1989, The American journal of physiology.
[57] J. Hughes,et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. , 2001, Journal of the American Society of Nephrology : JASN.
[58] L. Truong,et al. A role for uric acid in the progression of renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[59] J. Folkman,et al. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. , 2006, Experimental cell research.
[60] C. Winterford,et al. Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. , 1997, Journal of structural biology.
[61] H. Augustin,et al. Tension in the vasculature , 2009, Nature Medicine.
[62] A. Kroon,et al. Microvascular Abnormalities in Chronic Heart Failure: A Cross‐Sectional Analysis , 2003, Microcirculation.
[63] P. Carmeliet. Angiogenesis in health and disease , 2003, Nature Medicine.
[64] R. Roman,et al. Reversal of microvascular rarefaction and reduced renal mass hypertension. , 1997, Hypertension.
[65] Y. Sugisaki,et al. Peritubular capillary regression during the progression of experimental obstructive nephropathy. , 2002, Journal of the American Society of Nephrology : JASN.
[66] R. Garrick,et al. Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. , 2004, American journal of physiology. Heart and circulatory physiology.
[67] Gavin Thurston,et al. Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system , 2009, Nature Reviews Molecular Cell Biology.
[68] E. Keshet. Preventing pathological regression of blood vessels. , 2003, The Journal of clinical investigation.
[69] M. Goligorsky,et al. Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen. , 2004, Kidney international.
[70] J. Rohen,et al. Comparative morphological studies on blood vessels in eyes of normotensive and spontaneously hypertensive rats. , 1985, Experimental eye research.
[71] M. Kunimatsu,et al. Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. , 1996, Clinica chimica acta; international journal of clinical chemistry.
[72] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[73] I I Chen,et al. Development of microvascular rarefaction in the spontaneously hypertensive rat. , 1982, The American journal of physiology.
[74] M. Goligorsky,et al. Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. , 1996, The American journal of physiology.
[75] P. Weismann,et al. Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension , 2005, Cell Research.
[76] R. Iozzo,et al. BMP-1/Tolloid-like Metalloproteases Process Endorepellin, the Angiostatic C-terminal Fragment of Perlecan* , 2005, Journal of Biological Chemistry.
[77] W. Wood,et al. Prevention of arteriolar rarefaction in the spontaneously hypertensive rat by exposure to simulated high altitude. , 1986, Journal of hypertension.
[78] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[79] A. Ishisaki,et al. Human Umbilical Vein Endothelium-derived Cells Retain Potential to Differentiate into Smooth Muscle-like Cells* , 2003, The Journal of Biological Chemistry.
[80] J. Thyberg,et al. Increased Intimal Hyperplasia and Smooth Muscle Cell Proliferation in Transgenic Mice With Heparan Sulfate–Deficient Perlecan , 2004, Circulation research.
[81] Markus J Buehler,et al. Cyclic tensile strain triggers a sequence of autocrine and paracrine signaling to regulate angiogenic sprouting in human vascular cells , 2009, Proceedings of the National Academy of Sciences.
[82] P. Papanek,et al. Gender-specific protection from microvessel rarefaction in female hypertensive rats. , 1998, American journal of hypertension.
[83] T. Meyer,et al. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. , 1995, The Journal of clinical investigation.
[84] E. Im,et al. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. , 2005, Molecular biology of the cell.
[85] F. Murad,et al. Generation and role of angiostatin in human platelets. , 2003, Blood.
[86] M. Yoshioka,et al. Regression of the hyaloid vessels and pupillary membrane of the mouse , 1999, Anatomy and Embryology.
[87] H. Dvorak,et al. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. , 2003, The American journal of pathology.
[88] R R Markwald,et al. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. , 1997, Circulation research.
[89] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[90] R. Iozzo. Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.
[91] E. Popa,et al. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. , 2001, The Journal of clinical investigation.